Fox Chase Cancer Center has once again been recognized among the nation’s leading institutions for cancer care in the 2025–2026 U.S. News & World Report Best Hospitals rankings.
National Highlights
Fox Chase earned a #18 national ranking in Urology, reflecting continued excellence and innovation in both urology and urologic oncology.
The Center was also recognized as High Performing in Cancer, Gastroenterology & GI Surgery, and in five key cancer-related procedures and conditions:
- Colon Cancer Surgery
- Gynecologic Cancer Surgery
- Leukemia, Lymphoma & Myeloma
- Lung Cancer Surgery
- Prostate Cancer Surgery
A Trusted Leader in Complex Cancer Care
These distinctions reaffirm Fox Chase’s role as a national destination for complex cancer care. The High Performing designation in Cancer reflects strong clinical outcomes and multidisciplinary expertise across the institution.
“These results speak to the strength of our programs and the skill and commitment of our faculty and staff,” said Robert Uzzo, MD, MBA, FACS, President and CEO of Fox Chase Cancer Center. “We are proud to be recognized for the care we deliver every day, and even prouder of the people who make that care possible.”
A Year of Momentum
The past year has been one of Fox Chase’s most successful in recent memory—marked by growth in clinical programs, continued excellence in research, and unwavering dedication to serving patients and families with compassion and precision.
“Recognition like this is one reflection of who we are—but the real measure is in the lives we touch,” Uzzo said. “Our mission is clear, our foundation is strong, and our future is bright.”
To learn more about the U.S. News & World Report Best Hospitals rankings, visit health.usnews.com/best-hospitals.